series-c-plus
Stage
1
Investors
About
Peloton Therapeutics is a clinical stage pharmaceutical company developing first-in-class medicines targeting HIF-2α for cancer and other serious diseases, focusing on modulating previously undruggable protein interactions.
Explore Peloton Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.